Lightspeed · 22 October 2026

Why We're Backing Warp

Lightspeed

Lightspeed backs Warp, an AI-driven robotic lab automating drug discovery chemistry. As offshore providers face BIOSECURE Act restrictions and AI models improve, Warp aims to bring high-throughput lead optimization back to the US while capturing failed-experiment data to train better molecular prediction models.

Read the full post ↗

Topics: Biotech & Life Sciences · AI Infrastructure · Robotics

SandHill indexes 800+ venture capital blogs and newsletters and sends the best of them every Sunday. Browse the sources · browse by topic · read the blog.

Why We're Backing Warp | SandHill.io